A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
doi: https://doi.org/10.1101/2021.05.13.21256973

Article Information

doi 
https://doi.org/10.1101/2021.05.13.21256973
History 
  • June 19, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sumathi Sivapalasingam, M.D.1,†,*,
  2. David J. Lederer, M.D., M.S.1,*,
  3. Rafia Bhore, Ph.D.1,
  4. Negin Hajizadeh, M.D., M.P.H.2,
  5. Gerard Criner, M.D., F.A.C.P., F.A.C.C.P3,
  6. Romana Hosain, M.D., M.P.H.1,‡,
  7. Adnan Mahmood, M.D.1,
  8. Angeliki Giannelou, M.D.1,
  9. Selin Somersan-Karakaya, M.D.1,
  10. Meagan O’Brien, M.D.1,
  11. Anita Boyapati, Ph.D.1,
  12. Janie Parrino, M.D.1,
  13. Bret Musser, Ph.D.1,
  14. Emily Labriola-Tompkins, B.A.1,
  15. Divya Ramesh, Ph.D.1,
  16. Lisa A. Purcell, Ph.D.1,‡,
  17. Daya Gulabani, M.S., M.B.A.1,
  18. Wendy Kampman, M.D.1,
  19. Alpana Waldron, M.S.1,
  20. Michelle Ng Gong, M.D.4,
  21. Suraj Saggar, D.O.5,
  22. Steven J. Sperber, M.D., F.A.C.P., F.I.D.S.A.6,
  23. Vidya Menon, M.D., F.A.C.P.7,
  24. David K. Stein, M.D., F.A.C.P.8,
  25. Magdalena E. Sobieszczyk, M.D., M.P.H.9,
  26. William Park, M.D.10,
  27. Judith A. Aberg, M.D.11,
  28. Samuel M. Brown, M.D., M.S.12,
  29. Jack A. Kosmicki, Ph.D.1,
  30. Julie E. Horowitz, Ph.D.1,
  31. Manuel A. Ferreira, Ph.D.1,
  32. Aris Baras, M.D., M.B.A.1,
  33. Bari Kowal, M.S.1,
  34. A. Thomas DiCioccio, Ph.D.1,
  35. Bolanle Akinlade, M.D., M.B.A., F.A.C.P.1,
  36. Michael C. Nivens, Ph.D.1,
  37. Ned Braunstein, M.D.1,
  38. Gary Herman, M.D.1,
  39. George D. Yancopoulos, M.D., Ph.D.1,
  40. David M. Weinreich, M.D.1,
  41. for the Sarilumab-COVID-19 Study Team
  1. 1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
  2. 2Institute for Clinical Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York
  3. 3Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
  4. 4Montefiore – Moses, Bronx, New York
  5. 5Holy Name Medical Center, Teaneck, New Jersey
  6. 6Hackensack Meridian School of Medicine and Hackensack University Medical Center, Hackensack, New Jersey
  7. 7NYC Health + Hospitals/Lincoln, Bronx, New York
  8. 8Jacobi Medical Center, Bronx, New York
  9. 9Columbia University, New York, New York
  10. 10Pulmonary and Sleep Disorder Clinic, Valley Medical Center, Renton, Washington
  11. 11Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York
  12. 12Intermountain Medical Center and University of Utah, Salt Lake City, Utah
  1. ↵†Corresponding author:
    Sumathi Sivapalasingam, M.D. Email: sumathi.sivapalasingam{at}regeneron.com

  1. ↵* Contributed equally

Back to top
Posted June 19, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
medRxiv 2021.05.13.21256973; doi: https://doi.org/10.1101/2021.05.13.21256973
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area